Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 02/01/20
End: 03/01/24
Due: 03/01/25
Phase: N/A
Priority: Normal
Start: 10/01/18
End: 05/01/24
Due: 05/01/25
Phase: N/A
Priority: Normal
Start: 06/01/17
End: 07/01/22
Due: 07/01/23
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Observational Cohort of COVID-19 Patients in Hubei Province | NCT05615792 | Dao Wen Wang | user2@example.com | None | 2020-02-01 | 2024-03-01 | 2025-03-01 | - | - | 2025-07-14 |
| Immunomodulatory Therapy & VSA | NCT06696807 | Dao Wen Wang | user2@example.com | None | 2018-10-01 | 2024-05-01 | 2025-05-01 | - | - | 2025-07-14 |
| The Effects of Glimepiride in Patients With Type 2 Diabetes and Chronic Heart Failure | NCT05538819 | Dao Wen Wang | user2@example.com | None | 2017-06-01 | 2022-07-01 | 2023-07-01 | - | - | 2025-07-14 |